Diagnostic laboratory test of deep fungal infections and antifungal susceptibility testing

Chinese Journal of Infection and Chemotherapy

Volumn 7, Issue 4, 2007, Pages 289-292

  Liu, Wei ^a   Li, Ruo Yu ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; GALACTOMANNAN; RIBOSOME DNA; VORICONAZOLE;

ARTICLE; DRUG SENSITIVITY; HUMAN; IMMUNOCOMPROMISED PATIENT; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; POLYMERASE CHAIN REACTION; YEAST;

EID: 34548232626     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients; classification, diagnosis, and management[J]. Clin Infect Dis, 1993, 17(Suppl 2):S487-S491.
2. Edmond MB, Wallace SE, McClish DK, et at. Nosocomial bloodstream infections in United States hospitals: a three-year analysis[J]. Clin Infect Dis, 1999, 29(2): 239-44.
3. Kontoyiannis PD, Lewis RE. Antifungal drug resistance of pathogenic fungi[J]. Lancet,2002,359(9312): 1135-1144.
4. Kontoyiannis PD, Bodey PG. Invasive aspergillosis in 2002: an update[J]. Eur J Clin Microbiol Infect Dis, 2002, 21(3): 161-172.
5. Chinese source.
6. Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis[J]. J Microbiol,2005,43: 65-84.
7. Reimer LG, Wilson L, Weinstein MP. Update of detection of bacteremia and fungemia[J]. Clin Microbiol Rev, 1997, 10 (3): 444-465.
8. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis[J]. Lancet Infect Dis, 2005, 5(10): 609-622.
9. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. M27-A[S]. National Committee for Clinical Laboratory Standards, Villanova, Pa.
10. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard. M38-A[S]. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. Chinese source.
12. Chinese source.
13. Chinese source.
14. Chinese source.
15. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-Second edition. M27-A2 [S]. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voricoazole: analysis and proposal for interpretive breakpoints[J]. J Clin Microbiol,2006,44(3): 819-826.
17. Chinese source.
18. National Committee for Clinical Laboratory Standards. 2004. Method for antifungal disk diffusion susceotibility testing of yeasts; Approved guideline. M44-A[S]. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Rex JH, Pfaller MA, Rinaldi MG, et al. Antifungal susceptibility testing[J]. Clin Microbiol Rev, 1993, 6(4): 367-381.
20. Ghannoum MA, Rex JH, Galgiani JN. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome[J]. J Clin Microbiol, 1996, 34 (3): 489-495.
21. Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing: practical aspects and current challenges[J]. Clini Microbiol Rev,2001,14(4): 643-658.
22. Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited; a blueprint for the future for antifungal susceptibility testing[J]. Clin Microbiol Rev,2006,19(2): 435-447.
23. Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? [J]. Clin Infect Dis, 2002, 35(8): 982-989.
24. Odds FC, Motyl M, Andrade R, et al. Interlaboratory comparison of results of susceptibility testing with caspofungin against candida and aspergillus species[J]. J Clin Microbiol, 2004, 42(8): 3475-3482.
25. Espinel-Ingroff A. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991)[J]. J Clin Microbiol, 2003, 41(1): 403-409.
26. Liu W, Lionakis MS, Lewis RE, et al. Attenuation of itraconazole fungicidal activity of following preexposure of Aspergillus fumigatus to fluconazole[J]. Antimicrob Agents Chemother, 2003, 47(11):3592-3597.